Genome sequence of Staphylococcus aureus VC40, a vancomycin- and daptomycin-resistant strain, to study the genetics of development of resistance to currently applied last-resort antibiotics

Journal of Bacteriology

Volumn 194, Issue 8, 2012, Pages 2107-2108

  Sass, Peter ^a,c   Berscheid, Anne ^a   Jansen, Andrea ^a   Oedenkoven, Marion ^a   Szekat, Christiane ^a   Strittmatter, Axel ^b,d   Gottschalk, Gerhard ^b   Bierbaum, Gabriele ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c Institute for Pharmaceutical Biology   (Germany)

^d Axel Strittmatter   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; DAPTOMYCIN; GENOMIC DNA; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL GENETICS; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM MUTANT; DAPTOMYCIN RESISTANT STAPHYLOCOCCUS AUREUS; DELETION MUTANT; DNA EXTRACTION; GENOME ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NOTE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANT STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BASE SEQUENCE; DAPTOMYCIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENOME, BACTERIAL; MOLECULAR SEQUENCE DATA; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

STAPHYLOCOCCUS AUREUS;

EID: 84861205203     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.06631-11     Document Type: Note

References (15)

1. Berscheid A, Sass P, Weber-Lassalle K, Cheung AL, Bierbaum G. 2012. Revisiting the genomes of the Staphylococcus aureus strains NCTC 8325 and RN4220. Int. J. Med. Microbiol. doi:10.1016/j.ijmm.2012.01.002.
2. Cui L, Tominaga E, Neoh HM, Hiramatsu K. 2006. Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus. Antimicrob. Agents Chemother. 50:1079 -1082.
3. Gillaspy AF, et al. 2006. The Staphylococcus aureus NCTC 8325 genome, p 381-412. In Fischetti V, Novick R, Ferretti J, Portnoy D, Rood J (ed), Gram-positive pathogens. ASM Press, Washington, DC.
4. Gordon RJ, Lowy FD. 2008. Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin. Infect. Dis. 46(Suppl. 5):S350 -S359.
5. Hiramatsu K, et al. 1997. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350:1670 -1673.
6. Klimke W, et al. 2009. The National Center for Biotechnology Information's Protein Clusters Database. Nucleic Acids Res. 37:D216-D223.
7. Lowy FD. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339: 520-532.
8. Nair D, et al. 2011. Whole-genome sequencing of Staphylococcus aureus strain RN4220, a key laboratory strain used in virulence research, identifies mutations that affect not only virulence factors but also the fitness of the strain. J. Bacteriol. 193:2332-2335.
9. Perichon B, Courvalin P. 2006. Synergism between beta-lactams and glycopeptides against VanA-type methicillin-resistant Staphylococcus aureus and heterologous expression of the vanA operon. Antimicrob. Agents Chemother. 50:3622-3630.
10. Ruef C. 2004. Epidemiology and clinical impact of glycopeptide resistance in Staphylococcus aureus. Infection 32:315-327.
11. Schaaff F, Reipert A, Bierbaum G. 2002. An elevated mutation frequency favors development of vancomycin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 46:3540 -3548.
12. Seedorf H, et al. 2008. The genome of Clostridium kluyveri, a strict anaerobe with unique metabolic features. Proc. Natl. Acad. Sci. U. S. A. 105:2128 -2133.
13. Sieradzki K, Tomasz A. 2003. Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus. J. Bacteriol. 185:7103- 7110.
14. Tenover FC, Moellering RC, Jr. 2007. The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus. Clin. Infect. Dis. 44:1208 -1215.
15. Tenover FC, et al. 2009. Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapy. Int. J. Antimicrob. Agents 33:564 -568.